Department of Biostatistics and Translational Medicine
Author : Jędrzej Chrzanowski
In recent days, Aleksander Rycerz, Eng., a sixth-year medical student pursuing an Individual Course of Study in our Department, visited the Cancer Research Institute in Cambridge, UK. During his stay at the Institute, he actively participated in research on the photoacoustic imaging of ovarian cancers dependent on endometriosis, led by Dr. Monika Golińska, PhD. Since […]
We are pleased to announce that Ewelina Perdas, PhD, from our Department, has become one of the 114 laureates of the Bekker NAWA Program – Mieczysław Bekker Program! For one year, starting from May 2024, Dr. Perdas will collaborate with Prof. Theresa L. Whiteside at the UPMC Hillman Cancer Center at the University of Pittsburgh […]
We are delighted to highlight the recent achievement of our team members: prof. Wojciech Fendler, together with his former PhD student – Beata Małachowska, MD, PhD, a current postdoc at the Department of Radiation Oncology in Albert Einstein College of Medicine (NYC, NY, USA). Their latest work, published in iScience, provides groundbreaking insights into the […]
Dr. Konrad Stawiski has been elected as a member of the international working group focusing on artificial intelligence in oncological radiotherapy within the European Society for Radiotherapy and Oncology. Dr. Konrad Stawiski’s term will last for 3 years. The task of the working groups is to assist in developing clinical and technical guidelines, provide advice […]
In Poland, breast cancer poses an alarming health issue, affecting nearly 20,000 women annually. It is the second most common cause of cancer-related deaths, surpassed only by lung cancer. Ovarian cancer, although less common, is characterized by a very high mortality rate – 2,700 cases per year. One of the key factors increasing the risk […]
We are pleased to announce the recent grant success of our team! In the November results of the National Science Centre grant program OPUS 25, we have secured funding for the project “Predictive Potential of Circulating MicroRNA Biomarkers in Patients with High Familial or Genetic Risk of Cancer”. The project was scored as the 2nd […]
We are delighted to inform you that the clinical research project led by Dr Anna Matyjek, a nephrology specialist from our team, titled “B cell depletion therapy to improve outcomes of steroid-sensitive nephrotic syndrome in adults – the BOOSTER trial,” has received funding recommendation in the second edition of the Medical Research Agency’s Head-to-Head Research […]
We are pleased to announce that Prof. Wojciech Fendler has been elected as a member of the Scientific Committees of the Polish Academy of Sciences in the Committee on Clinical Sciences and the Committee on Human Genetics and Molecular Pathology. Congratulations! More information and full lists of the Committees’ composition are available here.
Despite significant progress in oncology in recent decades, only about 50% of patients with invasive bladder cancer (MIBC) affecting the muscle layer, survive five years after diagnosis. New hope comes from the combination of radiochemotherapy with the rapidly advancing field of immunotherapy. A member of our team, and a specialist in oncological radiotherapy from the […]
We cordially invite applications from young ambitious scientists for the project “Identification of Angiogenesis and Metabolic Markers in Endometriosis and its Associated Ovarian Epithelial Cancer using Photoacoustic Imaging and Data Exploration (ENDOVO),” under the supervision of Dr. Monika Golińska, funded by the POLONEZ BIS 3 program of the National Science Centre for the years 2023-2025. […]
